Biotechnology & Pharmaceutical

Thomson Geer provides a full range of legal services to the biotechnology and pharmaceutical industries.

We advise and assist on matters including protection of intellectual property, regulatory requirements, taxation, insurance, litigation and dispute resolution, mergers and acquisitions, joint ventures, corporate governance, research and clinical trial agreements, capital raising, research documentation, venture capital, and competition law.

Our clients include listed public companies, medical and biotechnology companies, pharmaceutical manufacturers and distributors, venture capitalists, research and development organisations, and start-up companies.

Our biotechnology and pharmaceutical services include:

  • Agreements
  • Corporate structure
  • Dispute resolution and litigation
  • Due diligence reviews
  • Employment, industrial relations, and occupational health and safety
  • Industry specific legislation
  • Information technology
  • Intellectual property
  • Joint ventures
  • Labelling, branding, and packaging
  • Mergers and acquisitions
  • Product liability
  • Property
  • Regulatory compliance
  • Risk management
  • Taxation issues
  • Venture capital raisings

    Key Contacts

    Dan Kramer, Partner, Thomson Geer
    David Zwi
    Eugene Fung
    Josh Simons, Partner, Thomson Geer
    Lucinda Smith, Partner, Thomson Geer
    Peter Le Guay, Partner, Thomson Geer
    Tony Conaghan, Partner, Thomson Geer
    Loretta Reynolds, Partner - Markets, Thomson Geer
    Partner, Markets
    Catherine Mustaca, Special Counsel, Thomson Geer
    Special Counsel
    Special Counsel
    Special Counsel
    Katrina Chambers, Special Counsel, Thomson Geer
    Special Counsel
    Philip Byrnes, Partner, Thomson Geer